KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Inventory Average (2016 - 2026)

Abbott Laboratories' Inventory Average history spans 18 years, with the latest figure at $6.7 billion for Q1 2026.

  • On a quarterly basis, Inventory Average rose 5.02% to $6.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $6.7 billion, a 5.02% increase, with the full-year FY2025 number at $6.3 billion, down 0.64% from a year prior.
  • Inventory Average hit $6.7 billion in Q1 2026 for Abbott Laboratories, up from $6.6 billion in the prior quarter.
  • Over the last five years, Inventory Average for ABT hit a ceiling of $6.8 billion in Q3 2025 and a floor of $5.4 billion in Q1 2022.
  • Historically, Inventory Average has averaged $6.5 billion across 5 years, with a median of $6.6 billion in 2023.
  • Biggest five-year swings in Inventory Average: grew 18.42% in 2023 and later dropped 4.21% in 2025.
  • Tracing ABT's Inventory Average over 5 years: stood at $6.0 billion in 2022, then increased by 11.03% to $6.6 billion in 2023, then fell by 1.61% to $6.5 billion in 2024, then increased by 1.45% to $6.6 billion in 2025, then increased by 2.13% to $6.7 billion in 2026.
  • Business Quant data shows Inventory Average for ABT at $6.7 billion in Q1 2026, $6.6 billion in Q4 2025, and $6.8 billion in Q3 2025.